More than one million people in the United States today are fighting blood cancer. While a traditional
allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks.
With our purified, high-precision investigational cell therapies we hope to not only replace patients' blood and immune systems with healthy ones, but also restore their lives.
The Head of Account Management for BMT (Bone Marrow Transplant), Cell Therapy at Orca Bio will lead a national team of Account Managers responsible for building strategic partnerships with leading transplant centers, academic hospitals, and commercial accounts. This senior leader will spearhead the establishment of a high touch / hyper care customer engagement account model designed to provide proactive and elevated support throughout onboarding, treatment initiation, and ongoing adoption to support the launch of Orca Bio’s precision cell therapy platform, with a primary focus on the company’s first asset, Orca-T. The role requires in-depth expertise in cell and gene therapy commercialization, hospital-based sales, and a proven track record of launching novel therapies in complex clinical settings.
This role is critical to the commercial success of Orca Bio’s precision cell therapy platform and Orca-T, ensuring transformative partnerships and exceptional patient outcomes in the evolving landscape of cell and gene therapy.